Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121816836 | 12181683 | 6 | F | 20160105 | 20160803 | 20160315 | 20160810 | PER | PHHY2016US032585 | NOVARTIS | 65.67 | YR | F | Y | 63.00000 | KG | 20160810 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121816836 | 12181683 | 1 | PS | SIMULECT | BASILIXIMAB | 1 | Intravenous (not otherwise specified) | 20 MG, (ON DAY 0 AND DAY 4) | 103764 | 20 | MG | ||||||||
| 121816836 | 12181683 | 2 | SS | SIMULECT | BASILIXIMAB | 1 | 103764 | ||||||||||||
| 121816836 | 12181683 | 3 | SS | MYCOPHENOLATE MOFETIL. | MYCOPHENOLATE MOFETIL | 1 | Oral | 1000 MG, BID | 44000 | MG | 0 | 1000 | MG | BID | |||||
| 121816836 | 12181683 | 4 | SS | MYCOPHENOLATE MOFETIL. | MYCOPHENOLATE MOFETIL | 1 | Oral | 750 MG, BID | 44000 | MG | 0 | 750 | MG | BID | |||||
| 121816836 | 12181683 | 5 | SS | MYCOPHENOLATE MOFETIL. | MYCOPHENOLATE MOFETIL | 1 | Oral | 500 MG, BID | 44000 | MG | 0 | 500 | MG | BID | |||||
| 121816836 | 12181683 | 6 | SS | MYCOPHENOLATE MOFETIL. | MYCOPHENOLATE MOFETIL | 1 | Oral | 250 MG, BID | 44000 | MG | 0 | 250 | MG | BID | |||||
| 121816836 | 12181683 | 7 | SS | MYCOPHENOLATE MOFETIL. | MYCOPHENOLATE MOFETIL | 1 | Unknown | UNK | 44000 | MG | 0 | ||||||||
| 121816836 | 12181683 | 8 | SS | GEODON | ZIPRASIDONE HYDROCHLORIDEIPRASIDONE MESYLATE | 1 | Oral | 80 MG, QD | Y | 0 | 80 | MG | QD | ||||||
| 121816836 | 12181683 | 9 | SS | GEODON | ZIPRASIDONE HYDROCHLORIDEIPRASIDONE MESYLATE | 1 | Oral | 40 MG, QD | Y | 0 | 40 | MG | QD | ||||||
| 121816836 | 12181683 | 10 | C | PROGRAF | TACROLIMUSTACROLIMUS ANHYDROUS | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 121816836 | 12181683 | 1 | Renal transplant |
| 121816836 | 12181683 | 2 | Immunosuppressant drug therapy |
| 121816836 | 12181683 | 3 | Renal transplant |
| 121816836 | 12181683 | 4 | Immunosuppressant drug therapy |
| 121816836 | 12181683 | 8 | Schizophrenia |
| 121816836 | 12181683 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 121816836 | 12181683 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 121816836 | 12181683 | Agranulocytosis | |
| 121816836 | 12181683 | Leukopenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 121816836 | 12181683 | 1 | 20131003 | 20131007 | 0 | |
| 121816836 | 12181683 | 4 | 20140708 | 0 | ||
| 121816836 | 12181683 | 5 | 20140923 | 0 | ||
| 121816836 | 12181683 | 6 | 20150825 | 20151120 | 0 | |
| 121816836 | 12181683 | 9 | 20151214 | 0 |